Renaissance Technologies’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-330,900
Closed -$860K 3710
2023
Q3
$860K Sell
330,900
-327,800
-50% -$852K ﹤0.01% 2404
2023
Q2
$2.33M Buy
658,700
+382,400
+138% +$1.35M ﹤0.01% 1898
2023
Q1
$1.17M Sell
276,300
-231,700
-46% -$978K ﹤0.01% 2376
2022
Q4
$8.36M Sell
508,000
-490,200
-49% -$8.06M 0.01% 1197
2022
Q3
$12.7M Buy
998,200
+332,800
+50% +$4.25M 0.02% 897
2022
Q2
$7.79M Buy
665,400
+276,700
+71% +$3.24M 0.01% 1250
2022
Q1
$2.37M Buy
388,700
+321,900
+482% +$1.96M ﹤0.01% 2115
2021
Q4
$612K Buy
+66,800
New +$612K ﹤0.01% 2981
2020
Q4
Sell
-1,024,507
Closed -$13.5M 3358
2020
Q3
$13.5M Buy
1,024,507
+98,800
+11% +$1.3M 0.01% 958
2020
Q2
$9.91M Buy
925,707
+308,700
+50% +$3.31M 0.01% 1230
2020
Q1
$1.98M Buy
617,007
+443,656
+256% +$1.42M ﹤0.01% 2054
2019
Q4
$328K Buy
173,351
+129,736
+297% +$245K ﹤0.01% 3047
2019
Q3
$85K Buy
+43,615
New +$85K ﹤0.01% 3277
2019
Q2
Sell
-109,306
Closed -$317K 3524
2019
Q1
$317K Sell
109,306
-85,200
-44% -$247K ﹤0.01% 3071
2018
Q4
$401K Buy
194,506
+152,205
+360% +$314K ﹤0.01% 2936
2018
Q3
$186K Buy
42,301
+16,436
+64% +$72.3K ﹤0.01% 3165
2018
Q2
$345K Buy
25,865
+11,446
+79% +$153K ﹤0.01% 2933
2018
Q1
$502K Sell
14,419
-6,535
-31% -$228K ﹤0.01% 2912
2017
Q4
$1.25M Sell
20,954
-471
-2% -$28.1K ﹤0.01% 2580
2017
Q3
$1.49M Sell
21,425
-649
-3% -$45.2K ﹤0.01% 2418
2017
Q2
$2.12M Buy
22,074
+6,104
+38% +$586K ﹤0.01% 2233
2017
Q1
$3.89M Buy
15,970
+4,813
+43% +$1.17M 0.01% 1844
2016
Q4
$10.9M Buy
11,157
+9,443
+551% +$9.21M 0.02% 1169
2016
Q3
$1.49M Buy
1,714
+1,217
+245% +$1.06M ﹤0.01% 2370
2016
Q2
$364K Buy
+497
New +$364K ﹤0.01% 2888
2014
Q2
Sell
-72
Closed -$40K 2764
2014
Q1
$40K Sell
72
-63
-47% -$35K ﹤0.01% 2766
2013
Q4
$75K Sell
135
-353
-72% -$196K ﹤0.01% 2759
2013
Q3
$307K Buy
+488
New +$307K ﹤0.01% 2463